186 related articles for article (PubMed ID: 10767798)
1. Neoadjuvant interleukin-12 immunogene therapy protects against cancer recurrence after liver resection in an animal model.
Jarnagin WR; Delman K; Kooby D; Mastorides S; Zager J; Brennan MF; Blumgart LH; Federoff H; Fong Y
Ann Surg; 2000 May; 231(5):762-71. PubMed ID: 10767798
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant treatment of hepatic malignancy: an oncolytic herpes simplex virus expressing IL-12 effectively treats the parent tumor and protects against recurrence-after resection.
Jarnagin WR; Zager JS; Klimstra D; Delman KA; Malhotra S; Ebright M; Little S; DeRubertis B; Stanziale SF; Hezel M; Federoff H; Fong Y
Cancer Gene Ther; 2003 Mar; 10(3):215-23. PubMed ID: 12637943
[TBL] [Abstract][Full Text] [Related]
3. Efficient cotransduction of tumors by multiple herpes simplex vectors: implications for tumor vaccine production.
Karpoff HM; Kooby D; D'Angelica M; Mack J; Presky DH; Brownlee MD; Federoff H; Fong Y
Cancer Gene Ther; 2000 Apr; 7(4):581-8. PubMed ID: 10811476
[TBL] [Abstract][Full Text] [Related]
4. Combination vascular delivery of herpes simplex oncolytic viruses and amplicon mediated cytokine gene transfer is effective therapy for experimental liver cancer.
Zager JS; Delman KA; Malhotra S; Ebright MI; Bennett JJ; Kates T; Halterman M; Federoff H; Fong Y
Mol Med; 2001 Aug; 7(8):561-8. PubMed ID: 11591892
[TBL] [Abstract][Full Text] [Related]
5. Tumor recurrence after partial hepatectomy for liver metastases in rats: prevention by in vivo injection of irradiated cancer cells expressing GMCSF and IL-12.
Aussilhou B; Panis Y; Alves A; Nicco C; Klatzmann D
J Surg Res; 2008 Oct; 149(2):184-91. PubMed ID: 18499129
[TBL] [Abstract][Full Text] [Related]
6. Increased vascular endothelial growth factor transcription in residual hepatocellular carcinoma after open versus laparoscopic hepatectomy in a small animal model.
Perry KA; Enestvedt CK; Hosack LW; Pham TH; Diggs BS; Teh S; Orloff S; Winn S; Hunter JG; Sheppard BC
Surg Endosc; 2010 May; 24(5):1151-7. PubMed ID: 19915910
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of hepatocellular carcinoma by transfecting interleukin-12 and interleukin-2 fusion gene intrasplenically, an experimental study].
Yang JH; Fan RF; Qian QJ; You TG; Xue HB; Su CQ; Cao HF; Wu MC
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):740-3. PubMed ID: 12899748
[TBL] [Abstract][Full Text] [Related]
8. Prevention of hepatic tumor metastases in rats with herpes viral vaccines and gamma-interferon.
Karpoff HM; D'Angelica M; Blair S; Brownlee MD; Federoff H; Fong Y
J Clin Invest; 1997 Feb; 99(4):799-804. PubMed ID: 9045885
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of multiagent herpes simplex virus amplicon-mediated immunotherapy as adjuvant treatment for experimental hepatic cancer.
Delman KA; Zager JS; Bennett JJ; Malhotra S; Ebright MI; McAuliffe PF; Halterman MW; Federoff HJ; Fong Y
Ann Surg; 2002 Sep; 236(3):337-42; discussion 342-3. PubMed ID: 12192320
[TBL] [Abstract][Full Text] [Related]
10. [Combination therapy of murine liver cancer with IL-12 gene and HSV-TK gene].
Tang Z; Sun W; Chen S
Zhonghua Zhong Liu Za Zhi; 1999 Sep; 21(5):332-5. PubMed ID: 11776567
[TBL] [Abstract][Full Text] [Related]
11. In vivo interleukin-2 gene therapy of established tumors with herpes simplex amplicon vectors.
D'Angelica M; Karpoff H; Halterman M; Ellis J; Klimstra D; Edelstein D; Brownlee M; Federoff H; Fong Y
Cancer Immunol Immunother; 1999 Jan; 47(5):265-71. PubMed ID: 10022470
[TBL] [Abstract][Full Text] [Related]
12. In situ cancer vaccination: an IL-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activity.
Toda M; Martuza RL; Kojima H; Rabkin SD
J Immunol; 1998 May; 160(9):4457-64. PubMed ID: 9574551
[TBL] [Abstract][Full Text] [Related]
13. Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins.
Andreansky S; He B; van Cott J; McGhee J; Markert JM; Gillespie GY; Roizman B; Whitley RJ
Gene Ther; 1998 Jan; 5(1):121-30. PubMed ID: 9536273
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant interleukin-12 gene therapy for the management of colorectal liver metastases.
Alves A; Vibert E; Trajcevski S; Solly S; Fabre M; Soubrane O; Qian C; Prieto J; Klatzmann D; Panis Y
Cancer Gene Ther; 2004 Dec; 11(12):782-9. PubMed ID: 15472716
[TBL] [Abstract][Full Text] [Related]
15. Targeted IL-24 gene therapy inhibits cancer recurrence after liver tumor resection by inducing tumor cell apoptosis in nude mice.
Yang YJ; Chen DZ; Li LX; Sheng QS; Jin ZK; Zhao DF
Hepatobiliary Pancreat Dis Int; 2009 Apr; 8(2):174-8. PubMed ID: 19357032
[TBL] [Abstract][Full Text] [Related]
16. Cytokine gene transfer enhances herpes oncolytic therapy in murine squamous cell carcinoma.
Wong RJ; Patel SG; Kim S; DeMatteo RP; Malhotra S; Bennett JJ; St-Louis M; Shah JP; Johnson PA; Fong Y
Hum Gene Ther; 2001 Feb; 12(3):253-65. PubMed ID: 11177562
[TBL] [Abstract][Full Text] [Related]
17. Combined gene therapy with suicide gene and interleukin-12 is more efficient than therapy with one gene alone in a murine model of hepatocellular carcinoma.
Drozdzik M; Qian C; Xie X; Peng D; Bilbao R; Mazzolini G; Prieto J
J Hepatol; 2000 Feb; 32(2):279-86. PubMed ID: 10707868
[TBL] [Abstract][Full Text] [Related]
18. [Experimental study of the anti-tumor effects of directly administered packaging cell line of retroviral vector carrying IL-12 gene on hepatoma].
Yang J; Qian Q; Xue H
Zhonghua Yi Xue Za Zhi; 1999 Oct; 79(10):761-3. PubMed ID: 11715523
[TBL] [Abstract][Full Text] [Related]
19. [IL-12 gene treatment of hepatocellular carcinoma: experimental study].
Yang J; Qian Q; Xue H; Cao H; Cui Z; Shi W; Yang G; Wu M
Zhonghua Wai Ke Za Zhi; 1999 Apr; 37(4):202-4. PubMed ID: 11829818
[TBL] [Abstract][Full Text] [Related]
20. Regional treatment of hepatic micrometastasis by adenovirus vector-mediated delivery of interleukin-2 and interleukin-12 cDNAs to the hepatic parenchyma.
Hirschowitz EA; Naama HA; Evoy D; Lieberman MD; Daly J; Crystal RG
Cancer Gene Ther; 1999; 6(6):491-8. PubMed ID: 10608345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
